Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on May 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

NOI to Sole Source to QuVa Pharma, Inc.

Closed
NOI-OD-26-000038Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Agency

Department Of Health And Human Services → National Institutes Of Health Olao

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

(1)

JOFOC for 503B IV Narcotics Purchase NIH Clinical Center

PDFjustification-and-authorization

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
Office AddressBETHESDA, MD, 20892, USA
Contacts

Full Description

Show more

The purpose of this acquisition is to purchase 503b compounded Intravenous (IV) Narcotics for patient care. Market research has been conducted with only two responses, from QUVA, the known Compounder and distributor for these IV narcotics.  Through trade shows, continuous learning seminars and trade journals, the CC Pharmacy Department stays abreast of the industry and is current on the availability of singular distribution outlets for these medications.


•             Product Service Code: 6515 – Medical and Surgical Instruments, Equipment, and Supplies


•             NAICS Code: 325412 – Pharmaceutical Preparation Manufacturing


•             Place of Performance: NIH Clinical Center, Bethesda, MD 20892 USA


POTS: 26-000038


Description:


This is a notice of intent, not a request for a quotation.  A solicitation document will not be issued, and quotations will not be requested.


The National Institutes of Health (NIH) intends to award a one-year contract to QuVa Pharma, Inc., located at 3 Sugar Creek Center Boulevard, Sugarland, TX 77478, on a firm fixed price sole source award basis for the purchase of 503b compound Intravenous (IV) Narcotics for patient care.


The proposed vendor, QuVa Pharma Inc., is the Original Manufacturer and has not designated other distributors of IV narcotics in the U.S.


This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.  Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.


The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.


Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Huda Malik, Contract Specialist via email to huda.malik@nih.gov by May 6, 2026 at 9 am EST.